Potential of Pegylated Interferon Alpha-2a in Behcet Uveitis: A Report of Five Cases

被引：16
|
作者：
Bielefeld, Philip [1 ]
Devilliers, Herve [1 ]
Deschasse, Clemence [2 ]
Saadoun, David [3 ]
Seve, Pascal [4 ]
Muselier, Aurore [1 ]
Creuzot-Garcher, Catherine [2 ]
Besancenot, Jean-Francois [1 ]
Bron, Alain Marie [2 ]
机构：
[1] Univ Hosp, Dept Internal Med & Syst Dis, 2 Blvd Marechal de Lattre de Tassigny,BP77908, F-21079 Dijon, France
[2] Univ Hosp, Dept Ophthalmol, Dijon, France
[3] Grp Hosp Pitie Salpetriere, Dept Internal Med 1, Paris, France
[4] Hop Croix Rousse, Hosp Civils Lyon, Dept Internal Med, Lyon, France
来源：
OCULAR IMMUNOLOGY AND INFLAMMATION | 2016年 / 24卷 / 05期
关键词：
LONG-TERM EFFICACY; THERAPY; DISEASE; SAFETY;
D O I：
10.3109/09273948.2015.1010652
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：599 / 602
页数：4
相关论文
共 50 条
  • [41] Ischaemic colitis during pegylated interferon-alpha monotherapy for chronic hepatitis B: A case report
    Liu, Yu
    Chen, Hui
    Xu, Zhi-Ying
    MEDICINE, 2023, 102 (14) : E33378
  • [42] Lichenoid Dermatitis From Interferon alpha-2a in a Patient With Metastatic Renal Cell Carcinoma and Seronegative HCV
    Bush, Amelia E.
    Hymes, Sharon R.
    Silapunt, Sirunya
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (07) : 714 - 716
  • [43] Malignant lymphoma associated with Behcet's disease: A report of 2 cases
    Meydan, Ahmet Deniz
    Gursel, Bilge
    Ozbek, Nilgun
    Can, Bilge
    Kandemir, Bedri
    TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (04) : 327 - 334
  • [44] Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
    Li, Ming-Hui
    Zhang, Lu
    Qu, Xiao-Jing
    Lu, Yao
    Shen, Ge
    Wu, Shu-Ling
    Chang, Min
    Liu, Ru-Yu
    Hu, Lei-Ping
    Li, Zhen-Zhen
    Hua, Wen-Hao
    Song, Shu-Jing
    Xie, Yao
    CHINESE MEDICAL JOURNAL, 2017, 130 (05) : 559 - 565
  • [45] KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy
    Rivero-Juarez, A.
    Gonzalez, R.
    Frias, M.
    Manzanares-Martin, B.
    Rodriguez-Cano, D.
    Perez-Camacho, I.
    Gordon, A.
    Cuenca, F.
    Camacho, A.
    Pineda, J. A.
    Pena, J.
    Rivero, A.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (04): : 360 - 365
  • [46] Comparision of the Side Effects Due To Interferon Alpha 2A Plus Ribavirin and Pegylated Interferon Alpha 2A Plus Ribavirin Combinations For Chronic Hepatitis C Infection
    Ural, Onur
    Demir, Nazlim Aktug
    Sumer, Sua
    Ural, Gaye
    Balci, Mehmet
    TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI, 2010, 27 (03): : 261 - 264
  • [47] Early administration of ultraviolet treatment is effective in pegylated interferon alpha-induced severe acute exacerbation of psoriasis: a case report and short review of the literature
    Tekin, N. S.
    Ustundag, Y.
    Tekin, I. O.
    Koca, R.
    Altinyazar, H. C.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (01) : 101 - 103
  • [48] Pegylated Interferon Alpha 2b for Treatment of Ocular Surface Squamous Neoplasia: A Pilot Study
    Karp, Carol L.
    Galor, Anat
    Lee, Yunhee
    Yoo, Sonia H.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2010, 18 (04) : 254 - 260
  • [49] Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World
    Sun, Yingxin
    Cai, Yifeng
    Cen, Jiannong
    Zhu, Mingqing
    Pan, Jinlan
    Wang, Qian
    Wu, Depei
    Chen, Suning
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Low dose and dose escalating therapy of interferon alfa-2a in the treatment of refractory and sight-threatening Behcet's uveitis
    Onal, S.
    Kazokoglu, H.
    Koc, A.
    Akman, M.
    Bavbek, T.
    Direskeneli, H.
    Yavuz, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (02) : S113 - S114
12345